Merck Quarterly Financial Report Q1_2012 - Welcome (optimized for printing)

Print this page

Quarterly Financial Report Q1_2012

Highlights – 1^st Quarter 2012

Organic sales growth of 1.2% driven by Merck Serono and Merck Millipore, offsetting declines in Performance Materials and Consumer Health

EBITDA pre one-time items declines by 8.4% to € 675 million from € 737 million versus a very strong year-ago quarter

Group-wide restructuring process well underway

EBITDA pre one-time items

by quarter€ million

Merck Group | Sales by quarter (bar chart)

© Merck KGaA, Darmstadt, Germany, Last Update 2012/05/15